LGALS9 and neoplasm: We found that while ATMi or anti-Gal-9 alone only moderately decreased tumor growth, their combination markedly improved tumor growth control and enhanced survival in CT26 syngeneic mouse model even with only three injections of anti-Gal-9 antibody (Fig. 5B-E).